Author

Xu Yang

Chinese Academy of Medical Sciences & Peking Union Medical CollegeORCID 0000-0002-5752-7255Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xu yang1 paper · Guizhou University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Danming HeiD· 1 shared Hua Bai· 1 shared Jian ZhangiD· 1 shared Jianchun DuaniD· 1 shared Jie WangiD· 1 shared Lihui Liu· 1 shared Man LiiD· 1 shared Xu Liu· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Danming HeORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Co-targeting KRAS and BCL-2 induces pyroptosis and antitumor tertiary lymphoid structures

Xu Yang, Man Li, Jian Zhang, Danming He, Xu Liu, Lihui Liu, Jianchun Duan, Zhijie Wang, Hua Bai, Jie Wang

This study shows that combining KRAS and BCL-2 inhibition induces pyroptosis and tertiary lymphoid structures in KRAS G12D-mutant lung cancer, enhancing B-cell-dependent antitumor immunity.

bioRxiv · Oct 14, 2026 · PreprintCancer Biology